Ga naar de inhoud

<img width="517" height="100" src="https://collegeoncologie.be/wp-content/uploads/2018/12/CoO-logo_new.png" class="attachment-full size-full wp-image-1935" alt="" srcset="https://collegeoncologie.be/wp-content/uploads/2018/12/CoO-logo_new.png 517w, https://collegeoncologie.be/wp-content/uploads/2018/12/CoO-logo_new-300x58.png 300w" sizes="(max-width: 517px) 100vw, 517px" />

Home
Clinical guidelines
About
Legislation
News
Contact

Menu

Home
Clinical guidelines
About
Legislation
News
Contact

Oncogenetic guidelines

Hereditary endocrine cancers
Skin cancer syndromes
Li-Fraumeni and Cowden syndromes
Hereditary forms of breast and ovarian cancer

Hereditary endocrine cancers

National guideline on Pheochromocytomoma/paraganglioma
National guideline on Von Hippel Lindau
National guideline on MEN 1
National guideline on MEN 2

Skin cancer syndromes

National guideline on Birt-Hogg-Dubé syndrome
National guideline on familial atypical multiple mole melanomaBirt-Hogg-Dubé syndrome
National guideline on neurofibromatosis type 1
National guideline on neurofibromatosis type 2

Li-Fraumeni and Cowden syndromes

National guideline on Cowden syndromes
National guideline on Li Fraumeni

Hereditary forms of breast cancer and ovarian cancer

National guideline on BRCA1/2 and p53

<img width="517" height="100" src="https://collegeoncologie.be/wp-content/uploads/2018/12/CoO-logo_new.png" class="attachment-full size-full wp-image-1935" alt="" srcset="https://collegeoncologie.be/wp-content/uploads/2018/12/CoO-logo_new.png 517w, https://collegeoncologie.be/wp-content/uploads/2018/12/CoO-logo_new-300x58.png 300w" sizes="(max-width: 517px) 100vw, 517px" />

Clinical guidelines
About
Legislation
Press
Contact

Subscribe to our newsletter

Copyright © 2024 Belgian Board of Oncology – Privacy Policy

Powered by Dropsolid